As COVID-19 spreads across low- and middle-income countries, billions of people are vulnerable to variants that could resist vaccines and put the world back at square one in tackling this pandemic.
So why isn’t the vaccine already available to everyone, everywhere? It comes down to supply and distribution. Rich countries have bought up the majority of the supply and are hoarding even what they don’t need. Meanwhile, low- and middle-income countries are struggling to roll out the doses they do...
Jenny Ottenhoff
Read more recent COVID-19 vaccine content with our Vaccine Access Test and our new series Pandemica.
The COVID-19 pandemic is an unfortunate reminder that diseases don’t respect borders. The virus has swept the globe, infecting nearly 140 million people worldwide, and drastically impacting lives and livelihoods, with disproportionate impacts on people living in poverty and women and girls. In late 2020, the race to secure global vaccine access began, with hopes of finally ending the pandemic for everyone, everywhere.
At ONE,...